-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate, in Adults Aged 50 and ...
Join fellow educators and visionary business school leaders from across the Europe, Middle East and Africa regions in St. Julian's, Malta to examine current megatrends and how they affect the region’s ...